JOHN C LIESKE, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 42527
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about JOHN C LIESKE at bizstanding.comMayo Clinic - John C Lieske MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Endocrinology & Metabolism Physicians & Surgeons
Phone:
(507) 284-9991 (Phone)
Professional information
Professor Of Medicine At Mayo Clinic
Position:
Professor of Medicine at Mayo Clinic
Location:
Rochester, Minnesota Area
Industry:
Medical Practice
Work:
Mayo Clinic
-
Professor of Medicine
Education:
University of Chicago - The Pritzker School of Medicine 1982 - 1986
MD, Medicne Northwestern University 1978 - 1982
BS, Biomedical Engineering
MD, Medicne Northwestern University 1978 - 1982
BS, Biomedical Engineering
John C Lieske, Rochester MN
Specialties:
Nephrologist
Address:
Mayo Clinic, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine
Bernard Mitchell Hospital-University of Chicago Hospitals - Fellowship - Nephrology (Internal Medicine)
Emory University Hospital - Residency - Internal Medicine
Bernard Mitchell Hospital-University of Chicago Hospitals - Fellowship - Nephrology (Internal Medicine)
Emory University Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
John Charles Lieske, Rochester MN
Specialties:
Internal Medicine, Nephrology, Pathology
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
University of Chicago (1986)
Dr. John C Lieske - MD (Doctor of Medicine)
Hospitals:
Mayo Clinic Gastroenterology & Hepatology
200 1St St SW, Rochester 55905
Park Nicollet Methodist Hospital
6500 Excelsior Blvd, Saint Louis Park 55426
Saint Mary's Hospital at Amsterdam
427 Guy Park Ave, Amsterdam 12010
Mayo Clinic Gastroenterology & Hepatology
200 1St St SW, Rochester 55905
Park Nicollet Methodist Hospital
6500 Excelsior Blvd, Saint Louis Park 55426
Saint Mary's Hospital at Amsterdam
427 Guy Park Ave, Amsterdam 12010
200 1St St SW, Rochester 55905
Park Nicollet Methodist Hospital
6500 Excelsior Blvd, Saint Louis Park 55426
Saint Mary's Hospital at Amsterdam
427 Guy Park Ave, Amsterdam 12010
Mayo Clinic Gastroenterology & Hepatology
200 1St St SW, Rochester 55905
Park Nicollet Methodist Hospital
6500 Excelsior Blvd, Saint Louis Park 55426
Saint Mary's Hospital at Amsterdam
427 Guy Park Ave, Amsterdam 12010
Education:
Medical Schools
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1986
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1986
Methods And Compositions For Detecting And Treating Kidney Diseases Associated With Adhesion Of Crystals To Kidney Cells
US Patent:
6482934, Nov 19, 2002
Filed:
Mar 28, 2000
Appl. No.:
09/537226
Inventors:
F. Gary Toback - Chicago IL
John C. Lieske - Rochester MN
John C. Lieske - Rochester MN
Assignee:
ARCH Development Corp. - Chicago IL
International Classification:
C07H 2102
US Classification:
536 231, 530300, 530350, 435 6, 435 691, 435 71, 4353201, 514 2, 514 8, 514 21
Abstract:
An autocrine crystal adhesion inhibitor called CAI is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (COM) crystals to the cell surfaces. Novel amino acid sequences are shown for the amino-acid terminus and 6 interval fragments. Persons may be classified according to risk of developing kidney stones, by measuring the amount of CAI in a biological sample. Treatment efficacy is also monitored by this method. CAI is administered in vivo to prevent nephrolithiasis. A rapid, simple assay to detect agents that inhibit adhesion of COM crystals to the surface of kidney epithelial cells is characterized.
Methods And Compositions For Detecting And Treating Kidney Diseases Associated With Adhesion Of Crystals To Kidney Cells
US Patent:
2003015, Aug 21, 2003
Filed:
Nov 18, 2002
Appl. No.:
10/299043
Inventors:
F. Toback - Chicago IL, US
John Lieske - Rochester MN, US
John Lieske - Rochester MN, US
International Classification:
C12Q001/00, C07K007/08, A61K038/10
US Classification:
514/013000, 435/004000, 530/326000
Abstract:
An autocrine crystal adhesion inhibitor called CAI is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (COM) crystals to the cell surfaces. Novel amino acid sequences are shown for the amino-acid terminus and 6 interval fragments. Persons may be classified according to risk of developing kidney stones, by measuring the amount of CAI in a biological sample. Treatment efficacy is also monitored by this method. CAI is administered in vivo to prevent nephrolithiasis. A rapid, simple assay to detect agents that inhibit adhesion of COM crystals to the surface of kidney epithelial cells is characterized.
Treatment Of Nephrolithiasis And Urolithiasis Using 1,2,3,4,6-Penta-O-Galloyl-Beta-D-Glucose (Pgg)
US Patent:
2011027, Nov 10, 2011
Filed:
Jun 25, 2009
Appl. No.:
13/001094
Inventors:
John C. Lieske - Rochester MN, US
Sung-Hoon Kim - Seoul, KR
Sung-Hoon Kim - Seoul, KR
International Classification:
A61K 31/7028, A61P 13/02, A61P 13/12
US Classification:
514 25
Abstract:
The treatment of nephrolithiasis or urolithiasis by methods that include administration of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) or a salt or derivative thereof, or a pharmaceutically acceptable composition comprising the same are provided herein.
Evaluating Renal Function
US Patent:
2012000, Jan 5, 2012
Filed:
Mar 12, 2010
Appl. No.:
13/256121
Inventors:
Jesse C. Seegmiller - Rochester MN, US
John C. Lieske - Rochester MN, US
Timothy S. Larson - Rochester MN, US
Bradley E. Burns - Stewartville MN, US
John C. Lieske - Rochester MN, US
Timothy S. Larson - Rochester MN, US
Bradley E. Burns - Stewartville MN, US
Assignee:
Mayo Foundation for Medical Education and Rsearch - Rochester MN
International Classification:
H01J 49/26
US Classification:
250282
Abstract:
This document relates to methods and materials involved in evaluating renal function in a subject. For example, methods and materials for evaluating renal clearance using mass spectrometry techniques are provided.